T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.48B |
| 2 |
Kenvue
KVUE
|
+$1.5B |
| 3 |
Halliburton
HAL
|
+$1.12B |
| 4 |
Boeing
BA
|
+$950M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$920M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.64B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.66B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.56B |
| 5 |
Amazon
AMZN
|
+$1.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.76% |
| 2 | Healthcare | 16.83% |
| 3 | Financials | 10.91% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Option Care Health
OPCH
$3.61B
| $72.6M | 0.01% |
2,244,606
+252,530
| +13% | +$8.51M |
|
577
Relay Therapeutics
RLAY
$4.4B
| $72.4M | 0.01% |
8,608,946
+263,429
| +3% | +$2.83M |
|
578
CACI
CACI
$14.8B
| $72.3M | 0.01% |
230,170
-5,921
| -3% | -$1.98M |
|
579
Atkore
ATKR
$3.17B
| $72.2M | 0.01% |
483,670
-22,652
| -4% | -$3.42M |
|
580
Ameriprise Financial
AMP
$50.1B
| $72.1M | 0.01% |
218,681
-2,828
| -1% | -$965K |
|
581
Sanofi
SNY
$105B
| $72.1M | 0.01% |
1,343,339
-35,589
| -3% | -$1.9M |
|
|
ANSS
582
DELISTED
Ansys
ANSS
| $71.8M | 0.01% |
241,259
+48,673
| +25% | +$15.4M |
|
583
Axcelis
ACLS
$4.46B
| $71.6M | 0.01% |
438,975
-50,711
| -10% | -$8.92M |
|
584
Phillips 66
PSX
$91.9B
| $71.4M | 0.01% |
594,063
-22,527
| -4% | -$2.53M |
|
585
Casella Waste Systems
CWST
$5.78B
| $71.2M | 0.01% |
932,576
-157,733
| -14% | -$12.9M |
|
586
United Airlines
UAL
$41.3B
| $70.7M | 0.01% |
1,670,838
-526,200
| -24% | -$26.6M |
|
587
Ecolab
ECL
$77.5B
| $70.4M | 0.01% |
415,350
-2,675
| -0.6% | -$486K |
|
588
Kymera Therapeutics
KYMR
$9.46B
| $70.3M | 0.01% |
5,057,425
+50,277
| +1% | +$1.01M |
|
589
State Street
STT
$52.3B
| $70M | 0.01% |
1,045,051
-802,795
| -43% | -$56.6M |
|
|
BLD
590
DELISTED
TopBuild
BLD
| $69.6M | 0.01% |
276,734
+47,681
| +21% | +$13.1M |
|
591
Ryan Specialty Holdings
RYAN
$10.8B
| $68.5M | 0.01% |
1,416,253
+34,741
| +3% | +$1.61M |
|
592
Parker-Hannifin
PH
$134B
| $67.8M | 0.01% |
174,184
-1,785
| -1% | -$717K |
|
|
APLS
593
DELISTED
Apellis Pharmaceuticals
APLS
| $67.8M | 0.01% |
1,783,241
-5,288,985
| -75% | -$232M |
|
594
Xcel Energy
XEL
$49.3B
| $67.2M | 0.01% |
1,173,797
+96,187
| +9% | +$5.78M |
|
595
Autodesk
ADSK
$51.8B
| $67M | 0.01% |
323,990
-918,413
| -74% | -$193M |
|
596
Tenaris
TS
$26.7B
| $66.7M | 0.01% |
2,109,296
+1,914,614
| +983% | +$61.9M |
|
597
Aflac
AFL
$60.8B
| $66.6M | 0.01% |
867,206
+32,808
| +4% | +$2.44M |
|
598
Zai Lab
ZLAB
$2.91B
| $66M | 0.01% |
2,716,594
+91,479
| +3% | +$2.44M |
|
599
SEACOR Marine Holdings
SMHI
$263M
| $65.6M | 0.01% |
4,728,998
-203,884
| -4% | -$2.47M |
|
600
UiPath
PATH
$8.04B
| $65.5M | 0.01% |
3,827,667
-625,039
| -14% | -$10.4M |
|
Similar funds
T. Rowe Price Associates's Q3 2023 Portfolio in Review
As of Q3 2023, T. Rowe Price Associates held 2,959 positions worth $682B, down 4.9% from $718B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.7%. T. Rowe Price Associates opened 69 new positions and exited 71, leaving the 2,959-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2023 buy was Maplebear: 6,435,942 shares worth $191M.
- T. Rowe Price Associates added most to SLB Ltd in Q3 2023, an estimated $2.48B increase.
- T. Rowe Price Associates's biggest Q3 2023 reduction was Microsoft, cutting an estimated $2.64B.
- T. Rowe Price Associates fully exited Life Storage, Inc. in Q3 2023, selling an estimated $285M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $682B portfolio in Q3 2023.
- T. Rowe Price Associates opened 69 new positions and closed 71 in Q3 2023.
- T. Rowe Price Associates's portfolio value fell 4.9% quarter-over-quarter to $682B.
Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.